A new deep learning study using brain PET scans just confirmed it: Levodopa dose is the #1 driver of dyskinesia (LID) in Parkinson’s.
But that’s not the whole story.
Even when researchers corrected for dose, some people were still more likely to develop LID. Why? Because their brains already looked different -especially in areas like the putamen and sensorimotor striatum.
The study used Al to scan these patterns and found that your unique brain structure may set the stage for how your body responds to levodopa.
–
Official Website: https://tinyurl.com/Parkinsons-Health.
.
.
